On March 23, we had the privilege of honoring Professor Hegemann together with the Society for Biochemistry and Molecular Biology (GBM) at the 69th Mosbacher Kolloquium in Germany for his research in light-activated ion-channels. His insights could eventually contribute to the treatment of neuronal illnesses, which are based on impaired sensory cells – conditions that include Parkinson’s disease, autism and schizophrenia.
The GBM has been awarding this prestigious prize since 1963 to recognize pioneering achievements in fundamental biochemical and molecular biological research in Germany. Since 2012, Elsevier and our flagship BBA journals have been exclusive partners of the GBM and the sponsors of the medal.
Prof. Hegemann is a pioneer in one of the most dynamic fields of research in life sciences…
